TJ102
Ovarian Cancer, Renal Cell Carcinoma
IND-enablingActive
Key Facts
Indication
Ovarian Cancer, Renal Cell Carcinoma
Phase
IND-enabling
Status
Active
Company
About Phrontline Biopharma
A Chinese biotech developing innovative bispecific dual-payload ADCs to deliver next-generation frontline cancer therapies.
View full company profile